|
|
|
Out-of-Pocket Healthcare 2012
4/3/2012 | published by: Kalorama Information
Despite numerous attempts to reign in costs of healthcare, consumers are increasingly paying for healthcare products and services from their own monies. The costs of health care products and services continue
|
more...
|
$995.00
|
|
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
3/1/2012 | published by: Kalorama Information
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors
|
more...
|
$3,995.00
|
|
Triple Analysis: Prostate Cancer, Cancer Vaccines and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to
|
more...
|
$5,175.00
|
|
Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria
|
more...
|
$5,175.00
|
|
Brain Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Brain Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Brain Injury Global Clinical Trials Review, H1, 2012 provides data on the Brain Injury clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012 provides data on the Cerebral Infarction (Brain Infarction) clinical trial scenario. This
|
more...
|
$1,000.00
|
|
Triple Analysis: Breast Cancer, Pancreatic Cancer and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized
|
more...
|
$5,175.00
|
|
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Each of these three individual parts is
|
more...
|
$5,175.00
|
|
Cluster Headache Syndrome Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Cluster Headache Syndrome Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Cluster Headache Global Clinical Trials Review, H1, 2012 provides data on the Cluster Headache clinical trial scenario. This report provides elemental information and
|
more...
|
$1,000.00
|
|
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Peptides). Each of these three individual parts is
|
more...
|
$5,175.00
|
Related Markets
- Pharmaceuticals
- Generics Drugs
- Prescription Drugs
- Therapeutic Area
- CNS/Neurology
- Oncology/Hematology
Oncology/Hematology Reports
- Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Peptides
- Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Prostate Cancer, Cancer Vaccines and Protein Kinase Inhibitors
- Triple Analysis: Prostate Cancer, Apoptosis and Protein Kinase Inhibitors
- Triple Analysis: Prostate Cancer, Angiogenesis and Protein Kinase Inhibitors
